ANNE LOVE: Open Payments
NPI 1649749797 · ALABASTER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,916 in 75 payments from 17 companies in 2025. Trend: 2023 $1,430 · 2024 $3,238 · 2025 $4,916
Consulting: $2,850Food & beverage: $1,778Travel & lodging: $288
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 5 | $3,158 |
| Novartis Pharmaceuticals Corporation | 18 | $475 |
| Incyte Corporation | 19 | $313 |
| Organon LLC | 9 | $259 |
| GENZYME CORPORATION | 1 | $149 |
| Lilly USA, LLC | 2 | $131 |
| Paratek Pharmaceuticals, Inc. | 2 | $87 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $63 |
| PFIZER INC. | 3 | $44 |
Products named: EBGLYSS, OPZELURA, VTAMA, Rhapsido, COSENTYX, NUZYRA, Sotyktu, CIBINQO.
Industry payments across AL — which companies pay providers there.
